Literature DB >> 6357148

Studies on segmental pancreatic autotransplants in dogs.

R Munda, Y Berlatzky, M Jonung, R F Murphy, K Brackett, S N Joffe, J W Alexander.   

Abstract

Success with segmental pancreas transplants has been impaired by immunologic and technical considerations. Experiments were performed with autotransplants to avoid immunologic problems, allowing concentration on surgical techniques. Survival of splenic lobe pancreas autotransplants in pancreatectomized dogs was extended with relocation of the graft from the groin to the abdominal cavity and distal arteriovenous fistula to increase graft flow. Fibrosis of the graft occurred regardless of the method of duct treatment, latex (Neoprene) or Silastic injection or free intraperitoneal drainage. Hormonal responses in normoglycemic animals showed normal insulin levels (6 +/- 0.8 microU/mL) as compared with controls (5.4 +/- 0.9 microU/mL), while peak levels during arginine stimulation were higher in dogs with autotransplants (39.7 +/- 20 microU/mL) than in controls (15.1 +/- 1.9 microU/mL. Pancreatic polypeptide basal levels in animals with transplants were 42 +/- 2.2 pg/mL as compared with 256 +/- 28 pg/mL in controls, with no response to bombesin or protein meal stimulation. In this model, splenic lobe was capable of maintaining normoglycemia with avoidance of ketogenic amino acid patterns. Continuous fibrosis was the biggest threat to islet survival.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6357148     DOI: 10.1001/archsurg.1983.01390110058013

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  2 in total

1.  Endocrine response to intragastric and intravenous glucose challenge in the denervated dog pancreas.

Authors:  H Köhler; I Schröter-Printzen; R Nustede; M Barthel; R Ebert; A Schafmayer
Journal:  Int J Pancreatol       Date:  1992-04

2.  Evaluation of insulin secretion after pancreas autotransplantation by oral or intravenous glucose challenge.

Authors:  P Calhoun; K S Brown; D A Krusch; E Barido; A H Farris; W G Schenk; L E Rudolf; D K Andersen; J B Hanks
Journal:  Ann Surg       Date:  1986-11       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.